Skip to main content

Beneficial ownership — 13D / 13G

87,314 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
Driehaus Capital Management LLC SONX Sonendo, Inc. 13G/A 4.85% 2y
WOLVERINE ASSET MANAGEMENT LLC CSTAF Constellation Acquisition Corp I 13G/A 1.97% 2y
Paradigm Biocapital Advisors LP CRBP Corbus Pharmaceuticals Holdings, Inc. 13G 0% 2y
Zambon SpA (“ZSPA”) SVRA Savara Inc 13G/A 3.46% 2y
WOLVERINE ASSET MANAGEMENT LLC BRAC Broad Capital Acquisition Corp Common Stock 13G/A 0.74% 2y
Garo H. Armen INKT MiNK Therapeutics, Inc. 13D 9.68% 2y
WOLVERINE ASSET MANAGEMENT LLC ESYN EnerSyn Global Inc. 13G/A 0% 2y
Greater Miami Jewish Federation, Inc. RDVT Red Violet, Inc. 13G/A 8.2% 2y
WINDACRE PARTNERSHIP LLC HLF Herbalife Ltd. 13G/A 8.98% 2y
Magnetar Financial LLC WHLR Wheeler Real Estate Investment Trust, Inc. 13G/A 9.8% 2y
LONE PINE CAPITAL LLC DKS Dick's Sporting Goods, Inc. 13G/A 5% 2y
T. Rowe Price Investment Management, Inc. CCC CCC Intelligent Solutions Holdings Inc. 13G 5.6% 2y
Nantahala Capital Management, LLC SYRE Spyre Therapeutics, Inc. 13G/A 0% 2y
Blue Owl Capital Holdings LP TRML Tourmaline Bio, Inc. Common Stock 13G 6.55% 2y
BHP Group Limited IE Ivanhoe Electric Inc. 13G/A 4.3% 2y
Gates Capital Management, Inc. MBC MasterBrand, Inc. 13G/A 7.2% 2y
Ionic Ventures, LLC BDRX Biodexa Pharmaceuticals Plc 13G/A 4.9% 2y
Cormorant Asset Management, LP LBPH Longboard Pharmaceuticals, Inc. Common Stock 13G/A 9.99% 2y
Select Equity Group, L.P. SCI Service Corp International 13G/A 3.3% 2y
Nantahala Capital Management, LLC RDNW RideNow Group, Inc. 13G/A 12.6% 2y
Jixun Foo HERE Here Group Ltd 13G 6.5% 2y
Opaleye Management Inc. SNWV SANUWAVE Health, Inc. 13G/A 9.09% 2y
CP BF Lending, LLC EBET EBET, INC. Common Stock 13G 9.99% 2y
SPRUCE HOUSE INVESTMENT MANAGEMENT LLC CVNA Carvana Co. 13G/A 8.4% 2y
Snyder Capital Management, L.P. OPLN OPENLANE, Inc. 13G/A 3.77% 2y
Redmile Group, LLC PLRX Pliant Therapeutics, Inc. 13G/A 4.5% 2y
VIKING GLOBAL INVESTORS LP TRVI Trevi Therapeutics, Inc. 13G/A 9.99% 2y
Deep Track Capital, LP JNCE Jounce Therapeutics, Inc. Common Stock 13G/A 0% 2y
Commodore Capital LP SLNO Soleno Therapeutics Inc 13G/A 2.3% 2y
Walleye Capital LLC VMCAF Valuence Merger Corp. I 13G 9.36% 2y
Almitas Capital LLC DTF Dtf Tax-Free Income 2028 Term Fund Inc 13G 5% 2y
MANGROVE PARTNERS IM, LLC CNTM ConnectM Technology Solutions, Inc. 13G/A 0% 2y
MANGROVE PARTNERS IM, LLC RNAC Cartesian Therapeutics, Inc. 13G/A 2.59% 2y
PRICE T ROWE ASSOCIATES INC /MD/ ELS Equity Lifestyle Properties Inc 13G 7.2% 2y
T. Rowe Price Investment Management, Inc. TCN Tricon Residential Inc. 13G 6.8% 2y
PRICE T ROWE ASSOCIATES INC /MD/ CMI Cummins Inc 13G 5.2% 2y
Point72 Asset Management, L.P. CHWY Chewy, Inc. 13G/A 1.3% 2y
T. Rowe Price Investment Management, Inc. BROS Dutch Bros Inc. 13G 6.6% 2y
T. Rowe Price Investment Management, Inc. TFX Teleflex Inc 13G/A 15% 2y
Westchester Capital Management, LLC ONMD OneMedNet Corp 13G/A 0% 2y
First Light Asset Management, LLC PLRX Pliant Therapeutics, Inc. 13G 6.14% 2y
Deer IX & Co. Ltd. WEAV Weave Communications, Inc. 13G/A 10.3% 2y
ORBIMED ADVISORS LLC ELEV Elevation Oncology, Inc. Common stock 13G 6.8% 2y
BAKER BROS. ADVISORS LP BCRX Biocryst Pharmaceuticals Inc 13G/A 4.98% 2y
CANADA PENSION PLAN INVESTMENT BOARD SRAD Sportradar Group AG 13G/A 38.5% 2y
Fourthstone LLC CBAN Colony Bankcorp Inc 13G/A 8.22% 2y
AWM Investment Company, Inc. KOPN Kopin Corp 13G 9.99% 2y
ARMISTICE CAPITAL, LLC PTN Palatin Technologies Inc 13G/A 4.99% 2y
Nantahala Capital Management, LLC ABEO Abeona Therapeutics Inc. 13G/A 9.9% 2y
T. Rowe Price Investment Management, Inc. HOLX HOLOGIC INC 13G 9.2% 2y